Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-12-07Clinical Trial Update: Cadonilimab Plus mFOLFIRINOX as Conversion Therapy in LAPC [Phase 2]
Phase 2 clinical trial exploring cadonilimab plus mFOLFIRINOX as conversion therapy in locally advanced pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2023-12-06Clinical Trial Update: RX-3117 in Combination With Abraxane® in Subjects With Metastatic Pancreatic Cancer [Phase 1, Phase 2]
Clinical trial update for RX-3117 in combination with Abraxane in metastatic pancreatic cancer (Phase 1/Phase 2) with completed status and r…
-
CLINICAL_TRIALS trial_result · 2023-12-05Clinical Trial Update: Gemcitabine Hydrochloride, and Radiation Therapy in Patients With Borderline Resectable Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating gemcitabine hydrochloride with radiation therapy for borderline resectable pancreatic cancer (terminated; results p…
-
CLINICAL_TRIALS trial_result · 2023-11-24Clinical Trial Update: Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic Cancer [Phase 3]
Phase 3 trial investigating thalidomide for chemotherapy-related nausea and vomiting in pancreatic cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: Safety, Pharmacokinetics and Efficacy of CT-707, Toripalimab and Gemcitabine in Advanced Pancreatic Cancer [Phase 1, Phase 2]
Phase 1/2 trial update evaluating CT-707, toripalimab, and gemcitabine in advanced pancreatic cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Bemalenograstim Alfa for the Prevention in Patients With Colorectal Cancer/Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial update for Bemalenograstim Alfa in preventing outcomes for patients with colorectal or pancreatic cancer; status is…
-
CLINICAL_TRIALS trial_result · 2023-11-09Clinical Trial Update: Clinical Trial of Chemotherapy and Bemcentinib for Metastatic Pancreatic Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating chemotherapy in combination with bemcentinib for metastatic pancreatic cancer was terminated; results posted in…
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer [Phase 1, Phase 2]
Phase 1/2 trial of gemcitabine, nab-paclitaxel, and KPT-330 in advanced pancreatic cancer completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: PIPAC Nab-pac for Stomach, Pancreas, Breast and Ovarian Cancer [Phase 1]
Phase 1 trial update of PIPAC nab-paclitaxel for peritoneal carcinomatosis in stomach, pancreas, breast, and ovarian cancers with completed …
-
CLINICAL_TRIALS trial_result · 2023-10-31Clinical Trial Update: Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the Pancreas [Phase 2]
Phase 2 clinical trial evaluating combined chemotherapy, radiation therapy, and surgery for advanced pancreatic cancer has completed enrollm…
-
CLINICAL_TRIALS trial_result · 2023-10-18Clinical Trial Update: Disulfiram-Copper Gluconate in Met Pancreas Cancer w Rising CA19-9 on Abraxane-Gemzar, FOLFIRINOX or Gemcitabine [Phase 2]
Phase 2 trial evaluating disulfiram-copper gluconate in metastatic pancreatic cancer with rising CA19-9 during standard regimens; study term…
-
CLINICAL_TRIALS trial_result · 2023-10-18Clinical Trial Update: A Phase II, International Open Label Trial of Minnelide™ in Patients With Refractory Pancreatic Cancer [Phase 2]
Phase II open-label trial of Minnelide in patients with refractory pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-10-16Clinical Trial Update: Spleen Irradiation With Nanoliposomal Irinotecan Plus 5-FU and Leucovorin in Metastatic Pancreatic Adenocarcinoma [Phase 2]
Phase 2 clinical trial investigating splenic irradiation with nanoliposomal irinotecan plus 5-FU and leucovorin for metastatic pancreatic ad…
-
CLINICAL_TRIALS trial_result · 2023-10-02Clinical Trial Update: Intravenous Lidocaine for Pain Associated With Pancreatic Cancer and Chronic Pancreatitis [Phase 2]
Phase 2 clinical trial evaluating intravenous lidocaine for pain in pancreatic cancer and chronic pancreatitis has completed.
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Maintenance Rucaparib in BRCA1, BRCA2 or PALB2 Mutated Pancreatic Cancer That Has Not Progressed on Platinum-based Therapy [Phase 2]
Phase 2 trial of maintenance rucaparib in BRCA1/BRCA2 or PALB2 mutated pancreatic cancer after platinum-based therapy has been terminated; r…
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: High Dose Vitamin C Combined With Metformin in the Treatment of Malignant Tumors [Phase 2]
Phase 2 trial update evaluating high-dose vitamin C with metformin for malignant tumors including hepatocellular and pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: IMX-110 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update for IMX-110 in adults with advanced solid tumors across Phase 1 and Phase 2 is listed, with multiple solid tumor ind…
-
CLINICAL_TRIALS trial_result · 2023-09-22Clinical Trial Update: Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab in Pancreatic Cancer Patients [Phase 2]
Phase 2 trial evaluating nab-paclitaxel plus gemcitabine with or without tocilizumab in unresectable pancreatic carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-09-22Clinical Trial Update: Immune Checkpoint Inhibition in Combination With Radiation Therapy in Pancreatic Cancer or Biliary Tract Cancer Patients [Phase 2]
Phase 2 trial investigating immune checkpoint inhibitors combined with radiation therapy in metastatic pancreatic cancer and metastatic bili…
-
CLINICAL_TRIALS trial_result · 2023-09-01Clinical Trial Update: Tislelizumab Combined With Nab-paclitaxel and Gemcitabine for Recurrent Pancreatic Cancer [Phase 2]
Phase 2 trial updating tislelizumab with nab-paclitaxel and gemcitabine for recurrent pancreatic cancer is being investigated.
-
CLINICAL_TRIALS trial_result · 2023-09-01Clinical Trial Update: Borderline Resectable Pancreatic Cancer Neoadjuvant Chemoradiotherapy Clinicaltrial-1 [Phase 2]
Phase 2 clinical trial update for borderline resectable pancreatic cancer focusing on neoadjuvant chemoradiotherapy.
-
CLINICAL_TRIALS trial_result · 2023-09-01Clinical Trial Update: Study of Immunotherapy Combined With Chemotherapy in Locally Advanced and Metastatic Pancreatic Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating an immunotherapy combined with chemotherapy for locally advanced and metastatic pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2023-08-30Clinical Trial Update: SBRT Plus vNKT for Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial evaluating SBRT plus vNKT therapy for pancreatic cancer is ongoing, with status currently unknown.
-
CLINICAL_TRIALS trial_result · 2023-08-22Clinical Trial Update: Adjuvant Gemcitabine and Capecitabine Chemotherapy in Resected Pancreatic Cancer Following Neoadjuvant Chemotherapy [Phase 2]
Phase 2 trial of adjuvant gemcitabine and capecitabine chemotherapy after neoadjuvant therapy in resected pancreatic cancer is updating its …
-
CLINICAL_TRIALS trial_result · 2023-08-15Clinical Trial Update: Study of CBP501/Cisplatin/Nivolumab Combinations in Advanced Pancreatic Cancer [Phase 2]
Phase 2 clinical trial update for CBP501/Cisplatin/Nivolumab in advanced pancreatic cancer has been completed.